Sign Up
bf/NASDAQ:BEAM_icon.jpeg

COM:BEAMTX

Beam Therapeutics

  • Stock

USD

Last Close

23.58

22/11 21:00

Market Cap

2.40B

Beta: -

Volume Today

1.16M

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.00
-
0.00
53.92%
0.04
66,073.53%
0.05
29.13%
0.26
469.89%
cash conversion cycle
-29.49
-
cash per share
0.15
-
4.17
2,739.77%
2.03
51.38%
6.41
216.44%
21.35
232.96%
15.40
27.88%
15.42
0.16%
company equity multiplier
-0.57
-
1.25
317.00%
1.55
24.10%
1.84
18.95%
1.78
3.04%
1.83
2.57%
1.49
18.68%
days of inventory outstanding
days of payables outstanding
29.49
-
days of sales outstanding
2.11K
-
dividend yield
0.01
-
ebit per revenue
-4.18K
-
-5.53K
32.49%
-7.57
99.86%
-5.56
26.60%
-0.47
91.59%
ebt per ebit
1.02
-
2.55
151.32%
1.04
59.16%
1.47
40.64%
0.94
35.57%
0.77
18.61%
0.74
3.32%
effective tax rate
-0.06
-
0.61
1,073.32%
-0.00
100.24%
-0.32
21,355.38%
0.08
124.86%
-0.01
116.59%
-0.01
20.54%
enterprise value multiple
-32.70
-
31.71
196.98%
-12.11
138.17%
-58.08
379.77%
-10.37
82.15%
-6.69
35.50%
-11.74
75.61%
fixed asset turnover
0.00
-
0.00
54.01%
0.28
144,744.48%
0.26
6.16%
1.59
510.43%
free cash flow per share
-0.24
-
-0.95
303.55%
-1.86
96.05%
-2.40
28.63%
-1.76
26.60%
-0.38
78.56%
-2.37
528.24%
gross profit margin
1
-
1
0%
1
0%
1
0%
0.95
5.30%
interest coverage
-401.89
-
-84.67
78.93%
43.61K
51,603.56%
-22.13
100.05%
-3.78
82.91%
inventory turnover
long term debt to capitalization
0.17
-
0.28
62.03%
0.14
50.12%
0.19
33.33%
0.14
25.04%
net income per ebt
1
-
0.99
1.27%
1.00
1.43%
1.32
31.58%
0.92
30.11%
1.01
10.00%
1.01
0.27%
net profit margin
-4.36K
-
-10.68K
145.17%
-6.58
99.94%
-4.33
34.29%
-0.35
91.89%
operating cash flow per share
-0.21
-
-0.58
176.42%
-1.59
175.00%
-2.05
28.96%
-1.03
49.64%
0.32
131.18%
-1.93
701.03%
operating cycle
operating profit margin
-4.18K
-
-5.53K
32.49%
-7.57
99.86%
-5.56
26.60%
-0.47
91.59%
payables turnover
12.38
-
pretax profit margin
-4.35K
-
-8.11K
86.33%
-7.15
99.91%
-4.27
40.26%
-0.35
91.87%
price fair value
-58.06
-
4.92
108.47%
8.42
71.27%
15.54
84.55%
6.19
60.15%
3.73
39.70%
2.14
42.68%
receivables turnover
0.17
-
return on assets
-3.33
-
-0.69
79.28%
-0.50
27.18%
-0.57
12.97%
-0.23
59.22%
-0.20
15.14%
-0.09
53.79%
return on capital employed
1.89
-
-0.32
117.09%
-0.59
83.02%
-0.38
35.80%
-0.31
18.10%
-0.30
2.73%
-0.14
53.51%
return on equity
1.91
-
-0.86
144.95%
-0.78
9.64%
-1.04
34.38%
-0.41
60.46%
-0.36
12.96%
-0.14
62.42%
total debt to capitalization
0.20
-
0.29
43.62%
0.15
49.32%
0.20
33.55%
0.15
23.54%

All numbers in USD (except ratios and percentages)